New hope for controlling severe seizures in rare childhood epilepsy
NCT ID NCT01983722
Summary
This program provides expanded access to the medication stiripentol for patients with Dravet syndrome, a rare and severe form of childhood epilepsy. It allows patients aged 6 months and older who have hard-to-control seizures to receive this treatment outside of regular clinical trials. Participants will be monitored according to standard medical care while receiving the medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRAVET SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
Conditions
Explore the condition pages connected to this study.